• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content


Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

Like this presentation? Why not share!

Telemedicine and Advanced Technology Research Center (TATRC) - Slide 1






Total Views
Views on SlideShare
Embed Views



0 Embeds 0

No embeds



Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
Post Comment
Edit your comment
  • I
  • The USAMRMC is a Major Subordinate Command (MSC) of MEDCOM. The USAMRMC has: Six laboratory major subordinate commands: USAARL USAISR USAMRICD USAMRIID USARIEM WRAIR Two Advanced Development major subordinate commands: USAMMDA USAMMA Two Logistics major subordinate commands: USAMMA USAMMCE One IMIT major subordinate command: USAMITC One health facilities planning major subordinate command. One contracting command (support activity): USAMRAA
  • The USAMRMC’s Telemedicine and Advanced Technology Research Center (TATRC) manages programs related to existing DoD or Army R&D programs and advanced technology efforts. The USAMRMC’s Office of Congressionally Directed Medical Research Programs (CDMRP) manages extramural grant programs for research specified by Congress as a unique public/private partnership encompassing the military, scientists, disease survivors, advocates, consumers, and policy makers.
  • Organization chart describing TATRC’s current Research Portfolios. These portfolios are very diverse. By dividing up projects under portfolio topics, it allows TATRC to scale down PLRs to a specific topic area. It also allows the PM to look at the entire portfolio as a whole as well as to help him identify possible research Gaps. This is also a great resource for the CORS to identify tech readiness levels of their projects and pursue tech transfer opportunities within that specific portfolio.
  • This slides represents what we call the “Triple Helix”. A partnership of academia, industry and our sister services or other government entities. COL Friedl often refers to TATRC as a dating service. Facilitating relationships, partnerships and collaborations which lead to solutions to military relevant problems
  • On behalf of USAMRMC, TATRC pursues non-traditional strategies of advanced medical technology research and development. Non-traditional in two respects. Traditionally, U.S. Department of Defense medical research and development medical investment has been limited to infectious disease, chemical and biological warfare defense, military operational medicine (occupational and environmental health studies) and trauma or combat care casualty care research. The telemedicine and advanced technology research program is the first devoted solely to technology driven change as opposed to threat based research. Secondly, the program is differentiated from more traditional programs in its execution. Approximately 80% of the resources are derived from congressional special interest appropriations and it also is committed to a strategy of rapid prototyping, partnering and opportunistic expploitation as opposed to deliberate long range plans. This imbues the telemedicine and advanced technology program with a flexibility and agility uncharacteristic of more typical miliatry medical research and development programs.

Telemedicine and Advanced Technology Research Center (TATRC) - Slide 1 Telemedicine and Advanced Technology Research Center (TATRC) - Slide 1 Presentation Transcript

  • U.S. ARMY MEDICAL RESEARCH & MATERIEL COMMAND MG George Weightman - Commanding Colonel Karl Friedl, Director, Telemedicine & Advanced Technology Research Center (TATRC) Heather White, DoD Research Specialist, Office of Sponsored Programs Telemedicine and Advanced Technology Research Center … Fulfilling The Vision Thru R&D USAMRMC & TATRC Overview
  • Agenda
    • Command Structure/Organization
    • TATRC Background and Mission
    • Funding Mechanisms
    • Research Areas of Interest
    • Other Collaborative Opportunities
    • Closing
  • Medical Research and Materiel Command Overview Mission and Vision We are the world’s experts and leaders in the military relevant biomedical research and medical materiel communities, delivering the best medical solutions to enhance, protect, treat, and heal our warfighters. Provide medical knowledge and materiel lifecycle management to protect, treat and optimize warfighter health and performance across the full spectrum of operations. MISSION VISION
  • Command Relationships & Personnel USAMRMC HEADQUARTERS Medical Research & Technology Medical Advanced Development Medical Logistics Medical IM/IT Health Facilities Procure-ment Support WRAIR USAMMDA USAMRAA USAMMA USAMITC USAHFPA USAMMCE USAARL USAISR USAMRICD USAMRIID USARIEM USAMRMC Actual Personnel – Sep 2008 TATRC CDMRP MILITARY CIVILIAN CONTRACTOR TOTAL 1,004 2,384 2,929 6,317 15.89% 37.74% 46.37% 100.00%
  • Core Medical S&T Program Areas
    • Intramurally funded
    • Management costs from President’s Budget
    • 88% of S&T budget goes to in-house DOD labs ; The S&T objectives are placed into the POM cycle budget request (5-7 years out)
    • Military Infectious Diseases
    • Medical readiness
    • Vaccines
    • Biotechnology
    • Prophylaxis/treatment drugs
    • Diagnostics/prognostics
    • Vector control
    • Military Operational Medicine
    • Soldier selection and sustainment
    • Soldier performance
    • Warrior system modeling
    • Health hazards protection
    • Diagnostics/prognostics
    • Health monitoring
    • Clinical Rehabilitative Medicine
    • Prosthetics
    • Regenerative Medicine
    • Clinical Studies
    • Ocular and Auditory Rehabilitation & Repair
    • Combat Casualty Care
    • Lightweight medical equipment
    • Medical C4ISR
    • Trauma care
    • Health monitoring and diagnostic technology
  • Explore science and engineering technologies ahead of programmed research, leveraging other programs to maximize benefits to military medicine Be the government model of opportunity-driven research agility Mission Vision Telemedicine and Advance Technology Research Center
  • Evolution of TATRC DIN/PACS and Teleradiology Filmless Hospital Telemedicine and e-health Establishment of Gap Funding
    • Innovation in Managing Technology
    • Ability to Harness
      • Academic innovation
      • Congressional interests
      • Industrial investment
    • Aligning CSIs to the Larger Army Medical Research Objectives
    • Facilitate Innovations for the Command
    • Spearhead Collaboration Across Agencies
  • Congressional Special Appropriations – RDT&E
    • TATRC……..
    • Element of HQ, USAMRMC
    • Shapes Congressional Special Interest projects to DoD relevance
    • Leads DoD research in e-Health (computational biology & clinical informatics)
    • Bridges military medical research gaps & promotes innovative pilot research
    • Manages large cutting edge R&D programs
      • 15 Core Research Portfolios
        • > 800 active projects
        • SBIR/Gap funds management
    • 16-20% - Withhold
      • DHP, Economic improvement, SBIR/STTR, MRMC, TATRC
    TATRC FUNDING HISTORY - Since FY98, $2.10B managed R&D projects
  • Research Portfolios Key Product Lines Medical Robotics Dr. Gary Gilbert Health Information Technologies CDR Stephen Steffenson Medical Imaging Technologies Dr. Anthony Pacifico Advanced Prosthetics and Human Performance Mr. Troy Turner Computational Biology Dr. Jacques Reifman Biomonitoring Technologies Dr. Eva Lai Simulation and Training Technology Mr. Gene Wiehagen New Initiatives & Basic Science BHSAI BIC Current Staff 6 Military Officers 8 Civilians 54 IPAs (includes 10 part time) 88 Contractors 5 Consultants Coordinating Partnerships RAD I: Infectious Disease RAD II: Combat Casualty Care RAD III: Operational Medicine RAD IV: Clinical Rehab Medicine Infectious Disease Ms. Amber Stanley Trauma Dr. Tim Broderick Human Performance Optimization Dr. Sylvain Cardin Neuro- Rehabilitation MAJ Teresa Brininger Acoustic Trauma Dr. Michael Holtel Neuroscience Dr. Ken Curley Regenerative Medicine Dr. Eva Lai Nano-Medicine and Biomaterials Dr. Warren Grundfest Medical Logistics Mr. John DePasquale Integrative Medicine Dr. Jean Louis Belard Genomics/ Proteomics Dr. Anne Westbrook
  • Research & Development Strategies Link to the Warfighter New Ideas, Knowledge High Risk, High Payoff Innovation, Transition Academia + Government + Industry (Maximum Bang for Buck) Service Labs Academia DARPA Industry Expanded Resource Base International Coalitions Stryker Brigade – Deployed Forces Interagency Partners
  • www.tatrc.org
  • USAMRMC BAA 08-1 The USAMRMC Broad Agency Announcement (BAA) 08-1 is intended to solicit research ideas that work towards providing solutions to medical problems of importance to the American warfighter at home and abroad. SBIR/STTR Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) are highly competitive programs designed to allow small businesses to harness their innovative talents, with the incentive to profit from commercialization. AMEDD Advanced Medical Technology Initiative (AAMTI) The U.S. Army Medical Research and Materiel Command's (USAMRMC) mission is to provide solutions to medical problems of importance to the American war fighter at home and abroad. The AMEDD Advanced Medical Technology Initiative (AAMTI) plays a vital role in the fulfillment of these objectives.
  • USAMRMC Broad Agency Announcement (BAA) 08-1
    • *Provides a general description of USAMRMC’s research programs
      • Specific areas of interest
      • General information
      • Evaluation and selection criteria
      • Proposal preparation instructions
      • *BAA is continuously open, 24/7
      • *Accepts proposals on a rolling basis.
      • *Pre-proposals may be submitted and will be evaluated at any time
      • throughout the year.
  • Research Areas of Interest
    • Military Infectious Diseases Research Program
    • Combat Casualty Care Research Program
    • Military Operational Medicine Research Program
    • Medical Biological Defense Research Program
    • Medical Chemical Defense Research Program
    • Telemedicine and Advanced Technology Program
    • Special Programs
    • Military Infectious Diseases Research Program
      • Vaccines (characterization, development, pathology)
      • Antiparasitic Drugs (discovery, design, & development)
      • Vector Development (arthropod vectors & vector-borne diseases)
      • Therapeutic drug development (screen, synthesize, and develop)
    • Combat Casualty Care Research Program
      • Stop blood loss
        • Limit the immediate, short- and long-term deleterious consequences of severe hemorrhage
        • Non/Minimally invasive sensors to detect and warn of impending vascular collapse
        • Improved preservation, storage, transportability, and processing of red blood cells, platelets, and plasma
      • Traumatic Brain Injury
        • Non/Minimally invasive sensors or assays to rapidly diagnose the severity of brain injury
        • Drugs, biologics, or other agents to mitigate post-injury affects
      • Secondary Damage to Organs
      • Additional Aspects of Casualty Care
    • Military Operational Medicine Research Program
      • Injury Prevention and Reduction
      • Psychological Health and Resilience
      • Environmental Health and Protection
      • Physiological Health
    • Medical Biological Defense Research Program
      • Viral, Toxin and Bacterial Studies
      • Drug Development
        • Development, synthesis and testing of compounds that possess antiviral, antibacterial, immunomodulatory or antitoxin activities
      • Identification and Diagnosis of antigens and antibodies
    • Medical Chemical Defense Research Program
      • Maintain the Technologic Capability to meet present requirements and counter future chemical warfare agent threats.
      • Provide Medical Countermeasures for the individual soldier to maintain combat effectiveness and prevent or reduce injury from chemical warfare agents.
      • Provide Medical Management of Chemical Casualties to enhance survival and expedite the return-to-duty of chemical warfare agent casualties through definitive therapies and life support technologies.
    • Telemedicine & Advanced Technology Program
      • Medical Robotics – to treat patients in fixed and mobile medical facilities
      • Health Information Technologies
      • Medical Imaging Technologies – portable, high performance, decision support, advanced surgical cameras
      • Advanced Prosthetics & Human Performance
      • Computational Biology - analysis, interpretation, prediction, and modeling of biological data
      • Biomonitoring Technologies - remote and wireless
      • Simulation and Training Technology
      • Genomics and Proteomics - signatures and markers
      • Chronic Disease Management
    • Telemedicine Cont.
      • Infectious Disease - vaccines, therapeutic agents, diagnosis, vector control, wound infections, and sepsis
      • Neuroscience - training, treatment, prevention, protection, assessment, and diagnosis.
      • Regenerative Medicine – development of treatments for damaged/non-functional tissues and organs
      • Nanomedicine and Biomaterials – identify novel developments in materials science and biomaterials leading to new drug s and improved devices
      • Trauma - develop materials, therapies, treatments, and diagnostics that will improve trauma treatment
      • Medical Logistics – transformational technologies applied to core logistics systems, focusing on devices, practices, and business processes to improve military medical logistics.
  • Small Business Innovative Research (SBIR) & Small Business Technology Transfer (STTR) *Eligible companies submit proposals against a specific topic, which is prepared by a DoD subject-matter expert *Three Phase Process Phase I -startup phase, with awards up to $100,000 Phase II - up to $750,000,expand on Phase I results and explore commercialization potential Phase III - laboratory to the marketplace, no funds available for support *Solicitations are released only at specific times during the year. For more information: Small Business Administration’s (SBA) http://www.sbaonline.sba.gov/SBIR/indexsbir-sttr.html#sttr DoD SBIR/STTR program http://www.acq.osd.mil/osbp/sbir/overview/index.htm
  • AMEDD Advanced Medical Technology Initiative (AAMTI)
    • AAMTI is an OTSG-funded program initiated in 1999. Each FY $5,000,000 in P8 funds are MIPRed/FADed to AMEDD facilities to enable technology demonstrations.
    • The key objectives of the AAMTI are to:
    • Demonstrate Advanced Medical Technologies and their Impact on Cost, Access and Quality of Care
    • Provide Senior AMEDD Leadership with Medical Tech-Watch Capability
    • Encourage Medical Technology Entrepreneurship by Funding AMEDD Technology Innovators
  • Other Collaborative Opportunities
    • Subject Matter Experts for proposal review and panel review boards.
    • Job opportunities for graduates or PhD’s looking to work in the medical research arena.
    • Partnering with existing projects as a subcontractor.
  • Useful Websites
    • TATRC - www.tatrc.org
    • USAMRMC BAA 08-1 - www.usamraa.army.mil/pages/Baa-Paa/mrmcbaalist.cfm
    • USAMRMC Homepage https://mrmc.detrick.army.mil
    • AMEDD AAMTI Announcement - http://grants.tatrc.org/proposals
    • Grants.gov – http://www.grants.gov/
    • CDMRP - http://cdmrp.army.mil
  • Heather White DoD Research Specialist Office of Sponsored Programs ENG 329 Email: [email_address] Phone: 410-455-3140